We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Korean Scientist Faked Stem Cell Research

By Biotechdaily staff writers
Posted on 09 Jan 2006
Following an investigation, a panel at Seoul National University (Korea) has announced that Hwang Woo Suk, its leading scientist, falsified the results of his experiments to clone embryos and extract stem cells from them to match patients.

In an article in Science in June 2005, Dr. More...
Hwang claimed to have cloned human embryos by transferring the nucleus of an adult cell into an egg and then to have extracted stem cells from that egg that genetically matched patients, who would then be able to produce regenerated tissues that could treat their diseases.

Seoul University's Dean of Research Affairs, Dr. Roe Jung Hye, has reported that Dr. Hwang's team does not have scientific data to prove it has produced such stem cells. Furthermore, following extensive DNA testing, the investigative panel found that none of the stem cells created by Dr. Hwang were produced by cloning but were from fertilized eggs and were not designed specifically for patients. Now, the panel is also investigating a 2004 study by Dr. Hwang as well as his claim to have produced the first cloned dog. The panel is to announce it findings in mid-January, according to Dr. Roe.

In the meantime, Dr. Hwang has claimed that the authentic stem cells he developed were stolen from his lab, replaced by samples from MizMedi Hospital in Seoul, which participated in his research. However, he has resigned from the university and has apologized for the falsifications in his paper.

The episode has dashed the hopes of scientists worldwide who thought Dr. Hwang's work would be able to advance the technology for therapeutic cloning.



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.